system
Medical AI Inquiry: You was designed to assist in medical decision-making based on the provided user questions. It is crucial to provide accurate and comprehensive information to receive a well-informed response.  Labels: BACKGROUND, METHODS, RESULTS. Meshes: Adult, Body Mass Index, Body Weight, Contraceptive Agents, Female, Female, Humans, Injections, Intramuscular, Kaplan-Meier Estimate, Norgestrel, Obesity, Oregon, Ovulation, Pilot Projects, Prospective Studies, Time Factors, Young Adult.
user
Does levonorgestrel butanoate intramuscular injection reliably suppress ovulation for 90 days in obese and normal-BMI women : a pilot study? Context: We performed a pilot evaluation of a new formulation of levonorgestrel butanoate (LB) designed to be a long-acting injectable (6 months) contraceptive to determine pharmacodynamic end points in normal-body mass index (BMI) and obese women. Obese (BMI ≥30 kg/m A total of 14 women enrolled and completed the study [normal BMI n=9, median BMI 22.7kg/m
assistant
Return to ovulation was earlier than 6 months in both BMI groups but more so in the obese BMI group. Final Decision: no